Time-kill kinetics of anti-tuberculosis drugs, and emergence of resistance, in relation to metabolic activity of Mycobacterium tuberculosis

Thioridazine cures extensively drug-resistant tuberculosis (XDR-TB) and the need for global trials is now!

(2010) Leonard Amaral et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

A Balancing Act: Efflux/Influx in Mycobacterial Drug Resistance

(2009) G. E. Louw et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Resistant mutants of Mycobacterium tuberculosis selected in vitro do not reflect the in vivo mechanism of isoniazid resistance

(2009) Indra L. Bergval et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Feasibility of the GenoType MTBDRsl Assay for Fluoroquinolone, Amikacin-Capreomycin, and Ethambutol Resistance Testing of Mycobacterium tuberculosis Strains and Clinical Specimens

(2009) D. Hillemann et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Epidemiology of antituberculosis drug resistance 2002–07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance

(2009) Abigail Wright et al.   LANCET

A unified anti-mutant dosing strategy

(2008) X. Zhao et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Emerging Drugs for Active Tuberculosis

(2008) Ann Ginsberg   SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE